We have identified some of the molecular characteristics of the high-motility mesenchymal-like phenotype in our patient-derived cell model, most notably high gene expression levels of FN1, CHI3L1, and SERPINE1 in relation to other tumor-derived reactive glia. This evidence concerns the gene SERPINE1 and neoplasm.